Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC)

Clinical trial NCT00743964 · COMPLETED

Trial details

NCT number: NCT00743964
Sponsor: Samsung Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Gastric Cancer

Start date: 2008-04-01
Primary completion: 2009-10-01
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.